About the Authors

Michael Klein

Affiliation Medicinal Chemistry, Department of Chemistry, University of Gothenburg, Göteborg, Sweden

Montse Morillas

Affiliation Cell Signalling Unit, Department de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), Parc de Recerca Biomèdica de Barcelona (PRBB), Barcelona, Spain

Alexandre Vendrell

Affiliation Cell Signalling Unit, Department de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), Parc de Recerca Biomèdica de Barcelona (PRBB), Barcelona, Spain

Lars Brive

Affiliation Department of Cell and Molecular Biology, University of Gothenburg, Göteborg, Sweden

Marinella Gebbia

Affiliation Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada

Iain M. Wallace

Affiliation Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada

Guri Giaever

Affiliation Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada

Corey Nislow

Affiliation Department of Molecular Genetics, University of Toronto, Toronto, Canada

Francesc Posas

Affiliation Cell Signalling Unit, Department de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra (UPF), Parc de Recerca Biomèdica de Barcelona (PRBB), Barcelona, Spain

Morten Grøtli

grotli@chem.gu.se

Affiliation Medicinal Chemistry, Department of Chemistry, University of Gothenburg, Göteborg, Sweden

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: MK MM AV LB M. Gebbia IMW GG CN FP M. Grøtli. Performed the experiments: MK MM AV LB M. Gebbia IMW. Analyzed the data: MK MM AV LB M. Gebbia IMW GG CN FP M. Grøtli. Contributed reagents/materials/analysis tools: LB GG CN FP M. Grøtli. Wrote the paper: GG CN FP M. Grøtli.